Long-acting hydrogel-based depot formulations of tirzepatide and semaglutide for the management of type 2 diabetes and weight
Published in Advanced Therapeutics, 2026
Manuscript of my Stanford SURF project on GLP-1 RA delivery.
Recommended citation: d’Aquino, A. I., Dong, C., Nguyen, L. T., Yan, J., Jons, C. K., Saouaf, O. M., Song, Y. E., Eckman, N., Kapasi, S., Williams, C. M., Doulames, V., Sen, S., Manna, M. K., Alakesh, A., Lu, K., Hall, I., & Appel, E. A. (2026). Long-acting hydrogel-based depot formulations of tirzepatide and semaglutide for the management of type 2 diabetes and weight. Advanced Therapeutics, 2026;9:2. https://doi.org/10.1002/adtp.202500329
Download Paper
